Lupus Nephritis
An observational post-authorisation safety study (PASS) in Europe to further characterise and quantify long-term safety profile with respect to neurotoxicity, chronic nephrotoxicity, and malignancy with use of voclosporin
- Sponsor: Otsuka Pharmaceutical Netherlands B.V
- Link: Otsuka Voclosporin PASS - Health Research Authority (opens in a new tab)
Renal
National Registry of Rare Kidney Diseases (RaDaR)
- Sponsor: UK Kidney Association
- Link: Study Details | NCT06065852 | National Registry of Rare Kidney Diseases | ClinicalTrials.gov (opens in a new tab)
Vasculitis
Avacostar - A Post Authorization Safety Study (PASS) to Evaluate the Incidence of Safety Events of Interest in Patients Treated With Avacopan for ANCA-associated Vasculitis (AAV)
- Sponsor: Vifor Fresenius Medical Care Renal Pharma
- Link: Study Details | NCT05897684 | Avacostar - (PASS) | ClinicalTrials.gov (opens in a new tab)
UKIVAS (UK and Ireland Vasculitis Rare Disease Group)
- Sponsor: University of Oxford
- Link: UKIVas · UKIVas (opens in a new tab)
Longitudinal Protocol for Eosinophilic Granulomatosis with Polyangiitis
- Sponsor: University of Pennsylvania
- Link: https://vcrc.rarediseasesnetwork.org/research-study/5506 (opens in a new tab)
Closed studies
Closed studies will appear